Phreesia Stock Price, News & Analysis

Phreesia, Inc. (PHR) is a healthcare technology company focused on patient activation, helping patients take a more active role in their care. The company works with healthcare providers, life sciences companies and other organizations, offering patient-driven digital solutions for intake, outreach, education and more. According to its public disclosures, Phreesia was founded in 2005 and has enabled approximately 170 million patient visits in 2024—about one in seven visits across the U.S., a level of scale that it believes allows it to make meaningful impact on patient experience and healthcare outcomes.

Phreesia’s business is classified under Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) within the Professional, Scientific, and Technical Services sector. Its shares trade on the New York Stock Exchange under the ticker PHR. The company describes itself as a trusted leader in patient activation, with technology that supports healthcare organizations in engaging patients before, during and after their visits.

Core platform and patient activation focus

Across multiple press releases, Phreesia explains that it offers patient-driven digital solutions for intake, outreach, education and related workflows. These tools are designed to enhance the patient experience, drive efficiency for healthcare organizations and improve healthcare outcomes. Phreesia’s technology is used at the point of care to engage patients with tailored content, collect information and support clinical and operational processes.

The company’s platform underpins a large volume of patient interactions. Phreesia reports that it enabled approximately 170 million patient visits in 2024, representing roughly one in seven visits across the United States. This scale is presented by the company as an important factor in its ability to influence how patients interact with healthcare providers and how organizations manage those interactions.

Revenue streams and key segments

In its financial statements, Phreesia discloses three primary revenue categories:

• Subscription and related services
• Payment processing fees
• Network solutions

These categories reflect how the company monetizes its technology platform and related services. Subscription and related services revenue is associated with access to Phreesia’s software and services. Payment processing fees arise from processing payments within its platform. Network solutions revenue is tied to activities delivered through its network, which includes engagement with patients on behalf of healthcare and life sciences clients.

AccessOne acquisition and payment capabilities

Phreesia has disclosed a significant expansion of its payment-related capabilities through the acquisition of AccessOne Parent Holdings, Inc. AccessOne is described as a market leader in providing financing solutions for healthcare receivables, working with some of the largest health systems in the U.S. According to company communications, AccessOne takes minimal credit risk and offers healthcare providers a scalable, compliant and operationally efficient tool that improves collections without undermining patient trust.

Phreesia entered into an Agreement and Plan of Merger with AccessOne and subsequently completed the transaction, with AccessOne becoming a wholly owned subsidiary of Phreesia. The company has stated that it has partnered with clients to offer payment plans for many years and that adding AccessOne’s platform is a natural progression that it expects will integrate with its existing products and expand its addressable market in payment solutions.

Technology innovation: Phreesia VoiceAI

Phreesia has also described the launch of Phreesia VoiceAI, which it characterizes as an always-on, intelligent AI phone solution purpose-built for healthcare. VoiceAI uses advanced natural language processing and real-time workflow integration to help healthcare organizations manage high call volumes, streamline routine interactions and improve the patient experience without increasing staff workload.

According to the company, VoiceAI allows patients to resolve common requests using natural spoken language, then triages and routes those requests appropriately. The company highlights several capabilities of VoiceAI, including intelligent triage of call intent, responses grounded in clinical rules and real-time scheduling logic, the ability to handle multiple calls simultaneously, and integrated documentation through a secure web app with supported electronic medical records.

Recognition and industry positioning

Phreesia has been recognized in multiple industry rankings and awards. It reports being named to the 2025 Deloitte Technology Fast 500™, which ranks fast-growing technology and related companies in North America based on revenue growth over a defined period. Phreesia has also been named to the 2025 Capterra Shortlists in the Appointment Reminder and Appointment Scheduling categories, reflecting user reviews and search activity for software products.

In addition, the company has highlighted individual leadership recognition, such as a Phreesia executive being named to MM+M’s 2025 40 Under 40 list and another leader being included in Becker’s Hospital Review’s Rising Stars: 100 Healthcare Leaders Under 40. These recognitions are presented by Phreesia as evidence of its focus on client experience, sales performance and support for healthcare organizations.

Collaborations and content partnerships

Phreesia has announced a five-year collaboration with Sesame Workshop, the nonprofit behind Sesame Street, to educate and engage parents and caregivers of young children at the point of care. Through this collaboration, campaigns will run on Phreesia’s digital intake platform, using Sesame Street characters to share educational and entertaining messages on pediatric health topics.

The company indicates that these campaigns will focus on healthy habits, preventive care, routine checkups, vaccinations, screenings and children’s emotional wellbeing. Phreesia positions this collaboration as an example of how its network can be used to deliver evidence-based health recommendations in an accessible format during the check-in process for children’s medical appointments.

Corporate structure, governance and financing

Phreesia is incorporated in Delaware and has disclosed that it operates as an all-remote company with principal executive offices in Wilmington, Delaware. The company’s common stock trades on the New York Stock Exchange under the symbol PHR. Its SEC filings describe a capital structure that includes authorized common and preferred stock, with no preferred shares issued or outstanding as of the dates presented in the filings.

The company has also reported entering into a bridge loan credit agreement related to the AccessOne acquisition, involving a 364-day secured term loan, and an amendment to its existing senior asset-based lending facility with Capital One. These financing arrangements are described in detail in its Form 8-K filings and are tied to funding the AccessOne transaction and aligning covenants across its credit facilities.

Financial reporting and key metrics

In its quarterly results, Phreesia reports total revenue along with the average number of healthcare services clients (AHSCs) and total revenue per AHSC as key metrics. The company discusses net income or net loss, Adjusted EBITDA, cash flows from operating activities and free cash flow, and it provides reconciliations for non-GAAP measures where applicable. Management commentary emphasizes operating leverage, efficiency and the impact of acquisitions such as AccessOne.

Phreesia’s SEC filings and earnings releases also describe its use of non-GAAP financial measures, including Adjusted EBITDA, and explain why it does not provide reconciliations for certain forward-looking non-GAAP metrics due to the variability of items such as other income or expense and income tax effects.

Mission and impact

Across its communications, Phreesia consistently states that its mission is to make care easier every day for patients, providers and staff. By focusing on patient activation and digital engagement at scale, the company aims to enhance the patient experience, support healthcare organizations in managing complex workflows and contribute to improved healthcare outcomes.

For investors and analysts, Phreesia represents a technology-driven participant in the healthcare ecosystem, combining software-based patient engagement, payment-related capabilities and a growing network used by healthcare providers and life sciences organizations. Its disclosures highlight both its operational scale in patient visits and its ongoing investments in technology, acquisitions and partnerships.